Sio Capital Management, LLC 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Sio Capital Management, LLC disclosed 57 US equity positions worth $583.5m in its Q2 2026 13F filing. The largest position was AVR at 9.4% of the reported book, followed by COR and MMS. Against the Q1 2026 filing, it opened 12 new positions, added to 10 and reduced 20 among the top 50 holdings.
What did Sio Capital Management, LLC own in Q2 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | AVR ANTERIS TECHNOLOGIES GLOBAL | 9.4% | $54.6m | 5,545,984 | 3% | added | |
| 2 | COR CENCORA INC | Healthcare | 8.4% | $49.1m | 173,588 | 72% | added |
| 3 | MMS MAXIMUS INC | Industrials | 6.6% | $38.5m | 715,267 | -7% | reduced |
| 4 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 4.7% | $27.7m | 13,323,431 | – | new |
| 5 | GMED GLOBUS MED INC | Healthcare | 4.1% | $23.8m | 301,816 | – | new |
| 6 | GSK GSK PLC | Healthcare | 3.9% | $22.9m | 436,700 | 13% | added |
| 7 | TYRA TYRA BIOSCIENCES INC | Healthcare | 3.8% | $22.2m | 695,315 | 15% | added |
| 8 | WAY WAYSTAR HLDG CORP | Healthcare | 3.3% | $19.0m | 925,834 | -44% | reduced |
| 9 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 3.1% | $17.9m | 480,383 | – | new |
| 10 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 2.9% | $16.9m | 177,118 | 34% | added |
| 11 | CI THE CIGNA GROUP | Healthcare | 2.7% | $15.9m | 57,750 | – | new |
| 12 | SNY SANOFI SA | Healthcare | 2.7% | $15.5m | 364,200 | 52% | added |
| 13 | ICLR ICON PUB LTD CO | Healthcare | 2.6% | $15.3m | 88,186 | -71% | reduced |
| 14 | VTRS VIATRIS INC | Healthcare | 2.6% | $15.2m | 954,299 | – | new |
| 15 | CROSS CTRY HEALTHCARE INC | 2.5% | $14.5m | 1,098,393 | 0% | held | |
| 16 | RAPP RAPPORT THERAPEUTICS INC | 2.2% | $12.8m | 307,657 | -16% | reduced | |
| 17 | ABT ABBOTT LABORATORIES | Healthcare | 2.0% | $11.7m | 128,656 | -31% | reduced |
| 18 | CELC CELCUITY INC | Healthcare | 2.0% | $11.5m | 110,022 | -43% | reduced |
| 19 | ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 1.9% | $11.3m | 131,445 | 110% | added |
| 20 | REGN REGENERON PHARMACEUTICALS | Healthcare | 1.9% | $11.2m | 18,000 | – | new |
| 21 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 1.9% | $11.1m | 193,500 | – | new |
| 22 | MDT MEDTRONIC PLC | Healthcare | 1.9% | $11.1m | 142,500 | – | new |
| 23 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 1.9% | $11.0m | 1,075,274 | -28% | reduced |
| 24 | SENS SENSEONICS HLDGS INC | 1.6% | $9.0m | 1,592,692 | 1276% | added | |
| 25 | EYPT EYEPOINT INC | Healthcare | 1.5% | $8.9m | 623,130 | -14% | reduced |
| 26 | HELP CYBIN INC | 1.5% | $8.6m | 1,300,000 | – | new | |
| 27 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 1.4% | $8.1m | 97,305 | -63% | reduced |
| 28 | TARA PROTARA THERAPEUTICS INC | 1.3% | $7.3m | 1,921,872 | -2% | reduced | |
| 29 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 1.2% | $6.9m | 1,003,562 | 4% | added |
| 30 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.1% | $6.5m | 208,500 | – | new |
| 31 | AQST AQUESTIVE THERAPEUTICS INC | 1.1% | $6.2m | 1,486,175 | -23% | reduced | |
| 32 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.0% | $5.8m | 59,254 | -84% | reduced |
| 33 | SION SIONNA THERAPEUTICS INC | Healthcare | 1.0% | $5.6m | 127,808 | -57% | reduced |
| 34 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 0.9% | $5.3m | 539,493 | -44% | reduced |
| 35 | ZBIO ZENAS BIOPHARMA INC | 0.9% | $5.3m | 208,557 | -37% | reduced | |
| 36 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 0.9% | $5.2m | 73,952 | -14% | reduced |
| 37 | OKUR ONKURE THERAPEUTICS INC | 0.8% | $4.9m | 1,078,965 | 0% | held | |
| 38 | SVRA SAVARA INC | Healthcare | 0.7% | $3.8m | 617,675 | 1% | added |
| 39 | PMVP PMV PHARMACEUTICALS INC | Healthcare | 0.6% | $3.5m | 2,634,137 | -14% | reduced |
| 40 | AVAH AVEANNA HEALTHCARE HLDGS INC | Healthcare | 0.5% | $3.2m | 369,036 | – | new |
| 41 | OVID OVID THERAPEUTICS INC | Healthcare | 0.5% | $2.7m | 1,005,334 | -20% | reduced |
| 42 | IMNM IMMUNOME INC | Healthcare | 0.5% | $2.6m | 124,168 | -25% | reduced |
| 43 | ANTX AN2 THERAPEUTICS INC | 0.4% | $2.6m | 529,933 | -19% | reduced | |
| 44 | SERINA THERAPEUTICS INC | 0.3% | $1.9m | 1,000,000 | 0% | held | |
| 45 | ALGS ALIGOS THERAPEUTICS INC | 0.3% | $1.9m | 327,237 | 0% | held | |
| 46 | IBIO IBIO INC | 0.3% | $1.6m | 904,268 | 0% | held | |
| 47 | XLO XILIO THERAPEUTICS INC | 0.3% | $1.5m | 152,464 | 0% | held | |
| 48 | AORT ARTIVION INC | Healthcare | 0.2% | $1.1m | 48,481 | – | new |
| 49 | BBOT BRIDGEBIO ONCOLOGY THERAPEUT | 0.2% | $995.4k | 130,628 | 0% | held | |
| 50 | TELA TELA BIO INC | 0.1% | $477.2k | 636,300 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.